Sanbo Brain Science: The company's controlling shareholder, one of the actual controllers, and the chairman of the board has been ordered to await investigation.

Sanbo Neurology announced that on February 8, 2026, the company received a "Notice of Removal of Obligation to Await Investigation" issued by the Inner Mongolia Autonomous Region Supervision Commission. The relevant departments have lifted the obligation for the company's controlling shareholder and one of the actual controllers and chairman, Zhang Yang, to await investigation. Currently, the company is operating normally, and Zhang Yang is performing his duties as usual.